Overview

Gender

male

Kevin Buchi served as Chief Executive Officer of Cephalon, Inc. since December 2010 and through its $6.8 billion acquisition by Teva Pharmaceutical Industries in October 2011.

Kevin Buchi joined Cephalon in March 1991 and, since December 2010, served as Chief Executive Officer. From January 2010 through December 2010, Kevin Buchi was Chief Operating Officer. In this role, he managed the company's global sales and marketing functions, as well as product manufacturing, business development and investor relations.

From February 2006 through January 2010, Kevin Buchi served as Chief Financial Officer. At various times in his career at Cephalon, Kevin Buchi has had oversight of corporate finance, accounting, information systems, facilities, human resources and administration.

Kevin Buchi graduated from Cornell University with a Bachelor of Arts degree in chemistry. He was a synthetic organic chemist for the Eastman Kodak Company before going on to obtain a master's degree in management from the J.L. Kellogg Graduate School of Management at Northwestern University.

He worked for a large public accounting firm before beginning his career in the pharmaceutical industry with E.I. du Pont de Nemours and Company in 1983.

Kevin Buchi is a certified public accountant. He has previously served on the Boards of Directors of a number of public and private companies.